Financials data is unavailable for this security.
View more
Year on year Mizuho Medy Co Ltd 's revenues fell -37.49% from 17.58bn to 10.99bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 7.84bn to 3.77bn, a -51.85% decrease.
| Gross margin | 71.88% |
|---|---|
| Net profit margin | 31.83% |
| Operating margin | 44.08% |
| Return on assets | 19.01% |
|---|---|
| Return on equity | 22.66% |
| Return on investment | 21.25% |
More ▼
Cash flow in JPYView more
In 2023, Mizuho Medy Co Ltd increased its cash reserves by 18.19%, or 1.34bn. The company earned 3.99bn from its operations for a Cash Flow Margin of 36.32%. In addition the company used 270.45m on investing activities and also paid 2.38bn in financing cash flows.
| Cash flow per share | 195.17 |
|---|---|
| Price/Cash flow per share | 8.26 |
| Book value per share | 846.83 |
|---|---|
| Tangible book value per share | 846.36 |
More ▼
Balance sheet in JPYView more
| Current ratio | 8.78 |
|---|---|
| Quick ratio | 7.62 |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -52.00% and -51.85%, respectively. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked above the industry average relative to its peers.
| Div yield(5 year avg) | 4.23% |
|---|---|
| Div growth rate (5 year) | 32.85% |
| Payout ratio (TTM) | 59.90% |
| EPS growth(5 years) | 32.64 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -22.87 |
More ▼
